Five-year Local Control Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer

被引:0
|
作者
Chakravarthy, A. [1 ]
Adams, S. [2 ]
Spicer, D. [3 ]
Lymberis, S. [2 ]
Goldberg, J. D. [2 ]
Schneider, R. J. [2 ]
Pietenpol, J. A. [1 ]
Formenti, S. [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] NYU, New York, NY USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词
D O I
10.1016/j.ijrobp.2010.07.505
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S209 / S210
页数:2
相关论文
共 50 条
  • [41] Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer
    Formenti, SC
    Spicer, D
    Skinner, K
    Cohen, D
    Groshen, S
    Bettini, A
    Naritoku, W
    Press, M
    Salonga, D
    Tsao-Wei, D
    Danenberg, K
    Danenberg, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 397 - 405
  • [42] Phase I study of neoadjuvant paclitaxel and concurrent radiation for locally advanced gastric cancer
    Safran, H
    Wanebo, HJ
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1331 - 1334
  • [43] Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
    Cai, Gang
    Cao, Lu
    Kirova, Youlia M.
    Feng, Yan
    Chen, Jia-Yi
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [44] Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
    Gang Cai
    Lu Cao
    Youlia M. Kirova
    Yan Feng
    Jia-Yi Chen
    Radiation Oncology, 14
  • [45] Five-year Results of Whole Breast Intensity Modulated Radiation Therapy for the Treatment of Early Stage Breast Cancer: The Fox Chase Cancer Center Experience
    Keller, Lanea M. M.
    Sopka, Dennis M.
    Li, Tianyu
    Klayton, Tracy
    Li, Jinsheng
    Anderson, Penny R.
    Bleicher, Richard J.
    Sigurdson, Elin R.
    Freedman, Gary M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (04): : 881 - 887
  • [46] Twice-weekly paclitaxel and radiation therapy in locally advanced breast cancer: Clinical and pathological response
    Formenti, SC
    Skinner, K
    Spicer, D
    Muggia, F
    Danenberg, K
    Danenberg, P
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 6 - 6
  • [47] Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive phase I/II trials
    Kao, J
    Conzen, SD
    Jaskowiak, NT
    Song, DH
    Recant, W
    Singh, R
    Masters, GA
    Fleming, GF
    Heimann, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1045 - 1053
  • [48] Five-year outcome of concurrent radiotherapy and chemotherapy in Saudi women with locally advanced cervical cancer: single-institution experience
    Al Asiri, Mushabbab
    Tunio, Mutahir
    Al Hadab, Abdulrehman
    Mohamed, Reham
    Bayoumi, Yasser
    Al Saeed, Eyad
    Al Arifi, Mohannad
    Al Amro, Abdulllah
    ANNALS OF SAUDI MEDICINE, 2013, 33 (04) : 327 - 333
  • [49] Long-term outcomes with concurrent carboplatin, paclitaxel, and radiation therapy in locally advanced, inoperable head and neck cancer
    Ferris, R. L.
    Agarwala, S. S.
    Cano, E.
    Heron, D. E.
    Johnson, J.
    Myers, E.
    Sandulache, V.
    Wang, Y.
    Bahri, S.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy
    Vlacich, Gregory
    Diaz, Roberto
    Thorpe, Steven W.
    Murphy, Barbara A.
    Kirby, Fwyndee
    Sinard, Robert J.
    Shakhtour, Bashar
    Shyr, Yu
    Murphy, Patrick
    Netterville, James L.
    Yarbrough, Wendell G.
    Cmelak, Anthony J.
    ONCOLOGIST, 2012, 17 (05): : 673 - 681